Drugs & Medications
58
Quality Score
Solid
Drugs & Medications
Low confidence
✍️ bumetric analysis
“
Drugs & Medications is an iOS app from KAVAPOINT in the Education category, currently rated 4.0★ across 49 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 58: Solid (established niche player). For a Education app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$2.6K
per month
→
12-mo forecast
$2.3K – $8.3K
per month
→
24-mo forecast
$2.1K – $19.1K
per month
INDIE tierFREE
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$75K
↳ What it cost to build · not monthly revenue
Likely range $55K – $100K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Pays back in ~2 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (75 MB) | +$10K |
| ⚙ Education complexity ×1.20 | +$12K |
Total estimate
$75K
ONE-TIME · EXIT VALUE
💵 Estimated acquisition value
$600K
↳ What it would sell for · not monthly revenue
Marketplace range $450K – $800K · 15× MRR multiple
💸
~8.0× return on build cost
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺 Ad-supported base | 15× MRR |
| 🏷 Education category multiple | +6% |
| ⭐ Small user base (<1K ratings) | -8% |
Final multiple
15× MRR
🔬
How we forecast this revenue
MEDIUM CONFIDENCEBaseline
$2.6K/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition, review-mined risks present
6 months
$2.2K – $5.2K
12 months
$2.3K – $8.3K
24 months
$2.1K – $19.1K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Pre-traction · 35/100INDIE TIERFREE (NO MONETIZATION)limited signalGrowth Velocity
5.0
Founder Strength
5.8
Product Quality
1.7
Revenue Strength
3.4
Monetization Maturity
0.5
Defensibility
6.0
Market Position
2.0
Operational Safety
3.8
- 💰 Revenue: Modest — $1K - $6K/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.0★ across 49 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: ⚠ last update 3179d ago — possibly dormant.
- ⚠️ Risk: High — rating drift -0.30 ★ (recent 50 vs lifetime), dormant (3179d since update).
🎯 For competitors: Vulnerable. Quality drift + slow updates create a clear opening for a fresh competitor with active dev cadence.
💵 For acquirers: Estimated asking range 12-22× monthly = $31K-$57K. Portfolio play ($60K/mo combined) commands premium. Discount applied for operational risk..
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 11 of 11 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Paid app ($0.00)METRIC | +$2,800 | |
| worth every pennyREVIEW | +$2,000 | |
| 5 starREVIEW | +$1,800 | |
| great valueREVIEW | +$1,600 | |
| excellent appREVIEW | +$1,500 | |
| Mature app (16y old)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| slowREVIEW | −$1,200 | |
| Good rating (4.0★)METRIC | +$800 | |
| Single-language (English only)METRIC | −$400 | |
| Pre-traction phase (49 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
🆕 What's New · v2.3
This update from Apple will improve the functionality of this app. No new features are included.
Updated for 64bit devices and for IOS8 and above
Updated for 64bit devices and for IOS8 and above
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Drugs & Medications
- Developer
- KAVAPOINT
- Bundle ID
- com.kavapoint.drugs
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 17+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $41.2K/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth49 ratings+-85% lifetimeShow 3-year history estimate ▾
Tracked (57 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
💰Pricing History$0.00 → $0.99 (+0%)
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
* Voted #1 Medication App for iOS by Doctors @ HealthTap #AppRx2014! http://t.co/sOrmepZIFm
---
* #1 paid medical app in multiple countries since 2009
* Top 5 paid medical app in as many as 46 countries since March 2010!!
* Top 100 app in many as 68 countries!!
* Top medical apps featured in iTunes Rewind
* Featured as "What's Hot" in multiple countries multiple times
***********************************************
NEW: Try our latest app : MedWords medical dictionary!
***********************************************
* Thousands of drugs and more new features and improvements… View full description on the official store →
---
* #1 paid medical app in multiple countries since 2009
* Top 5 paid medical app in as many as 46 countries since March 2010!!
* Top 100 app in many as 68 countries!!
* Top medical apps featured in iTunes Rewind
* Featured as "What's Hot" in multiple countries multiple times
***********************************************
NEW: Try our latest app : MedWords medical dictionary!
***********************************************
* Thousands of drugs and more new features and improvements… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 75 MB🔞 17+📱 iOS 8.0+🔖 v2.3🔄 updated 0d ago🌐 EN📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
8 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
💲
Went paid — introduced $0.99 price point
2010-06
📈
Crossed 100 ratings — social-proof flywheel kicking in
2010-04
📈
Crossed 50 ratings — social-proof flywheel kicking in
2010-01
📈
Crossed 10 ratings — social-proof flywheel kicking in
2010-01
⭐
Rating ↑ 1.75 → 2.40 (improved 0.65★)
2009-11
⭐
Rating ↓ 2.50 → 2.00 (dropped 0.50★)
2009-11
⭐
Rating ↓ 3.00 → 2.50 (dropped 0.50★)
2009-11
🚀
First tracked snapshot — initial data captured
🗣
Voice of Customer
Based on 302 reviews across 3 markets● 80% positive · ● 8% neutral · ● 13% negative · Rating drift: -0.30★ (declining — recent 50: 3.7★ vs lifetime: 4.0★)
VADER compound sentiment per quarter (−1 = fully negative, +1 = fully positive). Each point ≥ 5 reviews.
Sentiment by country (−1 to +1)
🇧🇷 BR
+0.56
🇺🇸 US
+0.52
🇬🇧 GB
+0.36
Top praise themes
user friendly ×6 side effects ×6 comes handy ×5 information about ×4 nursing student ×4 quick reference ×4 new meds ×3 useful work ×3
Top complaint themes
pill identifier ×6 couldn't find ×3 side effects ×3 drug ×10 information ×10 info ×9 search ×8 useful ×8
Risk signals
Refund mentions: 0.7%
🧪
Tech & Domain Intel — kavapoint.com
- Mail provider
- Mailgun (transactional)
- Tech stack
- Mailgun
Derived from public RDAP + DNS TXT records (no scraping, no login).
🌍
Multi-Country Performance
Available in 7 of 9 monitored markets| Market | Rating | Reviews | Current version |
|---|---|---|---|
| 🇦🇺 AU | 3.125★ | 8 | 3.125★ this version |
| 🇧🇷 BR | 2.16667★ | 6 | 2.16667★ this version |
| 🇨🇦 CA | 2.6★ | 5 | 2.6★ this version |
| 🇬🇧 GB | 4.22222★ | 9 | 4.22222★ this version |
| 🇮🇳 IN | 1★ | 1 | 1★ this version |
| 🇯🇵 JP | 4★ | 2 | 4★ this version |
| 🇺🇸 US | 4★ | 49 | 4★ this version |
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
More by KAVAPOINT
View all →📦 Portfolio summaryINDIE studio
2apps·$60K/mocombined
Lead-app heavy — top app contributes 68%
About this analysis
Why low confidence: only 49 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Drugs & Medications make per month?▴
Based on our ML-calibrated revenue forecast, Drugs & Medications earns approximately $41K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Drugs & Medications?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Drugs & Medications?▴
Drugs & Medications is published by KAVAPOINT on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Drugs & Medications's BU Score?▴
Drugs & Medications has a BU Score of 58/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.